Therma Bright Secures Major Distribution Deals as Compression Therapy Market Set to Hit $6.72B
Medical device company Therma Bright has secured significant distribution agreements and Medicare reimbursement approvals for its Venowave VW5 compression device, positioning itself for substantial growth in the rapidly expanding compression therapy market.
As the global compression therapy market prepares to expand from $4.18 billion in 2024 to $6.72 billion by 2033, Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) is making strategic moves to capture a significant share with its FDA-cleared Venowave VW5 device. The company has achieved remarkable success in securing Medicare and Medicaid reimbursement approvals in just 60 days, a process that typically takes much longer.
The company's recent partnership with DME Authority represents a major step forward, with commitments for $6 million in Venowave VW5 purchases during the first half of 2025 and similar projections for the second half. This agreement, alongside the deployment of 110 units in pilot tests and successful reimbursement for 25 units, signals strong market acceptance and potential for rapid growth.
What makes this development particularly significant is the Venowave VW5's unique position as the only Medicare-approved mobile mechanical compression system under HCPCS code E0683. The device offers clinically proven benefits, including a 64% increase in venous blood flow within two minutes of use, while addressing a critical gap in the market for portable, user-friendly compression therapy solutions.
The implications for healthcare providers and patients are substantial. With an aging population and rising healthcare costs, the availability of a reimbursable, mobile compression therapy solution could significantly improve treatment accessibility and patient compliance. For investors and industry observers, Therma Bright's rapid securing of reimbursement approvals and major distribution agreements suggests the potential for significant market penetration in a sector experiencing strong growth dynamics.